Levonicopto

Levofloxacin, the active ingredient in Levonicopto, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It is indicated for the treatment of bacterial conjunctivitis, keratitis and other ocular bacterial infections caused by susceptible organisms, providing a targeted antibacterial effect directly to the eye surface.

GNH USA supplies Levonicopto as a licensed, GDP‑compliant international pharmaceutical product, delivering the medication to hospitals, pharmacies and clinics worldwide under EU‑market standards. The company ensures quality control, regulatory compliance and reliable global distribution.

Levonicopto, a fluoroquinolone ophthalmic antibacterial, is used to manage bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of infection. - Keratitis: eradicates causative bacteria and promotes corneal healing. - Other ocular bacterial infections: treats bacterial blepharitis, dacryocystitis, and postoperative ocular infections.

Levonicopto may cause ocular and systemic adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Eye irritation: transient burning or stinging upon instillation. - Redness: conjunctival hyperemia. - Foreign body sensation: feeling of grit in the eye. - Increased tearing: lacrimation.

Serious or Rare Side Effects: - Corneal ulceration: worsening of corneal integrity. - Allergic reaction: swelling, itching, or rash around the eye. - Systemic hypersensitivity: fever, chills, or anaphylaxis.

When prescribing Levonicopto, clinicians should consider several safety and handling precautions. - Contraindication: avoid use in patients with known hypersensitivity to levofloxacin or other fluoroquinolones. - Caution in corneal disease: monitor closely in patients with pre‑existing corneal epithelial defects. - Pregnancy and lactation: use only if the potential benefit outweighs the risk, as safety data are limited. - Contact lens wearers: advise removal of lenses before instillation and delay reinsertion until the eye is dry. - Drug interactions: be aware of potential reduced efficacy when used with topical corticosteroids. - Store at room temperature: keep the solution below 25 °C, protect from light and moisture, and retain in the original container.

Levonicopto can interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid): - Concurrent fluoroquinolone therapy: may increase risk of tendon toxicity and systemic fluoroquinolone exposure. - Topical corticosteroids: can diminish antibacterial effect and increase risk of secondary infection.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may affect ocular surface tolerance. - Systemic NSAIDs: monitor for additive ocular irritation. - Herbal supplements containing quinine: potential additive QT prolongation risk.